February 5, 2026

An Indian investor will invest 595 million rubles in the development of pharmaceutical production in the Perm Krai.

Pharma

The head of the Kuedinsky Municipal District of Perm Krai, Florid Badrtdinov, reported at a regional government meeting on the plans of Indian investor Rajesh Sharma to develop pharmaceutical production in Kueda. In 2026–2030, the company "Advanced-Perm," which is controlled by the businessman, intends to invest 595 million rubles in the modernization and expansion of the existing facility.

The investment project involves the reconstruction of a plant for the production of parenteral drugs, which has been operating in Kueda since 2013. The plan includes updating production capacities and technological equipment, as well as creating new high-tech jobs.

Perm Krai Governor Dmitry Mahonin emphasized the region's interest in further developing pharmaceutical production. According to him, regional authorities have already provided the enterprise with support on infrastructure issues, including water supply, and expect stable development of the site and an increase in production.

The company became unprofitable starting from 2015 and was acquired by the "Advanced" Group of Companies in January 2019. After the change in ownership, a program for reconstruction and restoration of economic efficiency was announced. Rajesh Sharma, CEO of GC "Advanced" and a representative of the Indian business alliance, had previously announced plans for the development of the pharmaceutical plant.

According to "Rusprofile," Rajesh Sharma owns 99% of the shares in LLC "Advanced-Perm," while the remaining 1% is held by LLC "Advanced Trading." The company's general director is Inna Pestova. As of the end of 2024, the company's revenue amounted to 148.2 million rubles, with a net profit of 34.6 million rubles.

The "Advanced" Group of Companies specializes in the production and distribution of medications for treating tuberculosis, HIV/AIDS, hepatitis, and other socially significant diseases.

Regional authorities expect that the implementation of the project will strengthen Perm Krai's position in the pharmaceutical industry in the medium term.

Indian pharmaceutical companies are showing varied dynamics in their projects in Russia. For instance, Jodas Expoim continues construction of its production complex in the Voskresensk district of Moscow Oblast, despite regulatory violations and complaints about some of its products on the Russian market. Completion of the plant is scheduled for the third quarter of 2026.

Meanwhile, some Indian investors have paused their announced projects. At the end of 2025, Cadila Pharmaceuticals froze construction of a pharmaceutical complex and injection drug plant in Kemerovo Oblast. The project, worth approximately 10 billion rubles, introduced in 2024 and implemented jointly with the Russian Direct Investment Fund (RDIF), was expected to produce over 1 billion units of medication and up to 1,500 tons of active pharmaceutical ingredients (API).

Additionally, at the beginning of 2026, construction of a pharmaceutical complex and API factory in Murmansk Oblast, announced in 2023, effectively stopped. Regional authorities cited difficulties in cooperation with the investor. The project of the company "SafFarm," controlled by Indian Safecon Lifesciences and Eniker Bio Science, was valued at more than 9.2 billion rubles.

 

Source: VADEMECUM

Latest posts by email:
To subscribe to the newsletter, first Come in Either Register

Other news

Pharma

In today’s world, effective resource management is becoming an increasingly crucial aspect of successful business operations. This is especially true for industries where equipment plays a key role—such as pharmaceuticals, cosmetology, and the food industry.

02.10.2025
Pharma

A new administrative and production-warehouse complex of the pharmaceutical enterprise Farmstandart-UfaVITA has been commissioned in the center of Ufa. Investment exceeded 10 billion rubles, and new production lines are designed to produce 75 million medicine packages per year.

06.10.2026
Pharma

A Russian drugmaker, with the support of integrator IST-PAK, deployed an Italian SIEMPHARMA SRL counting-filling line for packaging tablets and capsules into plastic jars. The project was delivered despite a constrained shop floor and a fixed budget.

02.10.2026
Pharma

Farmasyntez Group commissioned a new pharmaceutical enterprise in Ussuriysk (Primorsky Krai). The plant with a design capacity of 12 million medicine packages a year was implemented under the import substitution program Pharma-2030; 90% of manufactured items are on the VED list.

01.10.2026
Pharma

Argumentum Pharma is completing the equipping of its new pharmaceutical plant in Moscow region's Dubna SEZ: high-tech automated filling and packaging lines have already been installed. Total investment in the project is estimated at 2.5 billion rubles, with commissioning planned before the end of 2026.

29.09.2026
Pharma

The Russian pharmaceutical manufacturer PFK "Renewal", operating under the Renewal brand, has commissioned a new production facility for the production of vital and essential medicines (VED) in the Novosibirsk region. The area of the complex exceeds 18.1 thousand square meters, and the design capacity reaches 100 million packages of finished products annually.

23.09.2026
Pharma

"VERTEX" is completing the commissioning of a blister-cardboard line with double-sided aluminum packaging, unique for its capacities. The new machine will become the tenth blister line of the enterprise and will allow to produce about 260 thousand packages by the end of 2026.

21.09.2026
Pharma

""""On Moscow Industry Day, Sergei Sobyanin opened a new production complex "Generium-Next" (GC "Farmstandart") at the Alabushevo site. The company will produce genetically engineered drugs for orphan and socially significant diseases for 8.5 billion rubles.

18.09.2026
Pharma

""PSK Pharma" company has completed a major project to modernize the production site of capsules with powder for inhalation at its own enterprise in the "Dubna" special economic zone. Investments exceeded 1 billion rubles, which made it possible to double the capacity of the line — from 80 to 160 thousand capsules per hour — and purchase new analytical and tablet equipment.

17.09.2026
Pharma

PJSC "Biosynthesis", one of the largest pharmaceutical enterprises in the Penza region, is preparing to launch a reconstructed production site for tablet dosage forms. The volume of investments in the project is 350 million rubles, and the implementation will increase the production of drugs, including those included in the list of VED.

16.09.2026
Pharma

Pharmaceutical manufacturer "Nizhpharm" announced the launch of a new line of packaging and packaging of soft dosage forms. The volume of investments in the project amounted to 158 million rubles, the maximum speed of the equipment reaches 270 packages per minute, which will increase production by 50%.

15.09.2026
Pharma

Gerresheimer, a German company specializing in glass, specialty glass, and plastic packaging for the pharmaceutical, cosmetic, and food industries, announced the commissioning of a new plant in Zhenjiang, China.

27.07.2026